Original Articles

The Comparison of Palliation of Surgical and Nonsurgical Methods of Unresectable Periampullary Cancers - Original Article

  • Mehmet Gülen
  • Muzaffer Akıncı
  • Barış Aşıcı
  • Ahmet Kocakuşak
  • Muammer Kaya
  • Ahmet Fikret Yücel

Med Bull Haseki 2005;43(4):0-0

Palliative surgery is usually employed in periampullary cancers since the cases where radical surgical management could be possible constitute only the minority. Because of being safe and easily applicable, transtumoral stent application provides an optimal treatment strategy as an alternative to the traditional bypass surgery. Despite studies which demonstrate that stent application into biliary channels should be as succesful as surgery, this comparison was not investigated by evaluating parameters such as survival, complications, life quality, costs, different palliation procedures and hospitalization time. To establish such a comparison, 53 patients with unresectable periampullary cancer who had been treated in our clinic with surgical and nonsurgical treatment modalities were evaluated retrospectively. The patients were divided in two groups regarding to the employed treatment modality either surgically (37 patients) or nonsurgically (16 patients). Both groups were compared in regard to complication rate, postoperative hospitalization time, necessity of repeat intervention and survival. The statistical analysis was made by GraphPad Prisma V.3 package program. Univariated variance analysis in the comparison between main groups, independent t-test between dual groups, and chi-square test between qualitative values were used. Overall survival and survival of operation methods were evaluated with Kaplan Meier and Log rank tests. The mean age in males and females were 62,53±10,81 years and 62,81±16,65 years, respectively. While the morbidity rate (24,3% versus 12,5%) and survival (7±1 months versus 5±1 months) were higher in the surgical group, there were no statistically significiant differences between the groups. While there was a small benefit in regard to necessity of repeat intervention in favour of surgery group, there was a benefit in regard to hospitalization time in the nonsurgical group, however these differences did not reach the level of the statistical difference (P>0,05). In conclusion; despite morbidity rates and hospitalization time are higher, the recurrence risk of jaundice is lower in surgical palliation methods. Nonsurgical palliation interventions seem to be more advantageous in patients with low life expectancy or in patients with high surgical risks because of concomitant diseases, whereas surgical palliation procedures are for patients with longer life expectancy with locally advanced diseases and with patients in whom an unresectable tumor is detected during surgery.

Article in Turkish(Use the link for full-text in Turkish)

1. Fontham ETH, Correu P. Epidemiology of pancreatic cancer. Surg Clin North Am 1989; 69: 551-67.
2. Fortner JG. Recent advances in pancreatic cancer. Surg Clin North Am 1974; 54: 4-8.
3. Gold EB, Goldin SB. Epidemiology of and risk factors for pancreatic cancer. Surg Clin North Am 1998; 71:67-91.
4. Jemal A, Thomas A, Murray T. Cancer statistics 2002. CA Cancer J Clin 2002; 52: 23-47.
5. Nuzzo G, Clemente G, Cadeddu F, Giovannini I. Palliation of unresectable periampullary neoplasms:"surgical" versus "non-surgical" approach. Hepatogastroenterol 2004; 51: 1282-5.
6. Stumpf M, Kasperk R, Bertram P, Truong S, Schumpelick V. Stellenwert der biliodigestiven Anastomose in derpalliativen Therapie des Pankreaskopfkarzinoms: Eine retrospektive Analyse an 107 Patienten. Zentralbl Chir 2001; 126: 913-6.
7. Lillemoe KD, Sauter PK, Pitt HD. Current status of surgical palliation of periampullary carcinoma. Surg Gyn Obst 1993; 176: 1-10.
8. Anderson HB, Baden H, Brahe NEB, Burcha F. Pancreaticoduodenectomy for periampullary carcinoma. J Am Coll Surg 1994; 179: 545-52.
9. Herbert C, Hoover J. Pancreatic and periampullary carcinoma. In: Zudema GD, Turcotte JG, eds. Shackelford's surgery of the alimentary tract. Philadelphia: WB Saunders Company, 1991: 59-87.
10. John G, Timotjy GD, Carter CD, Garden J. Carcinoma of the pancreatic head and periampullary region: Tumor staging with laparoscopy and laparoscopic ultrasonography. Ann Surg 1995; 221: 156-64.
11. Keith D, Lillemoe MD. Current management of pancreatic carcinoma. Ann Surg 1995; 221: 133-48.
12. Fitzgeralg PJ, Fortner JG, Watson RC. The value of diagnostic aids in detecting pancreas cancer. Cancer 1978; 41: 868-73.
13. Lewis WD, Finn JP, Jenkins RL. Use of magnetic resonance angiography in the pretransplant evaluation of portal vein pathologhy. Transplantation 1993; 56: 64-7.
14. Adamek HE, Albert J, Breer H, Weitz M, Schilling D, Riemann JF. Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography: a prospective controlled study. Lancet 2000; 356:190-3.
15. Rosch T, Hofrichter K, Frimberger E, Meining A, Born P, Weigert N, Allescher HD, Classen M, Barbur M, Schenck U, Werner M. ERCP or EUS for tissue diagnosis of biliary strictures? Gastrointest Endosc 2004; 60: 390-6.
16. Helene B, Niels M. Pancreaticoduodenectomy for periampullary adenocarcinoma. J Am Coll Surg 1987; 206:572-7.
17. Dooley WC, Cameron JL, Pitt HA. Is preoperative angiography useful in patients with periampullary tumors? Ann Surg 1990; 211: 649-53.
18. Michellassi F, Erroi F, Dawson PJ. Experience with 647 consecutive tumors of duodenum, ampulla, head of the pancreas and distal common bile duct. Ann Surg 1989; 210: 544-56.
19. Pasquali C, Sperti C, Filipponi C, Pedrazzoli S. Epidemiology of pancreatic cancer in Northeastern Italy: incidence, resectability rate, hospital stay, costs and survival (1990-1992). Dig Liver Dis 2002; 34: 723-31.
20. Shyr YM, Su CH, Wang HC, Wi WY. Comparison of resectable and unresectable periampullary carcinomas. J Am Coll Surg 1994; 178: 369-78.
21. Nacase A, Matsumato Y, Uchida K. Surgical treatment of cancer of the pancreas and periampullary region. cumulative results in 57 institutes in Japan. Ann Surg 1977; 185: 52-7.
22. Rogers CM, Adams JT, Schwartz SI. Carcinoma of the extrahepatic bile ducts. Surgery 1981; 194: 447-55.
23. Lees CD, Zajdonski A, Cooperman AM, Hermann RE. Carcinoma of the bile ducts. Surg Gyn Obst 1980;150: 721-6.
24. Fujino Y, Suzuki Y, Kamigaki T, Mitsutsuji M, Kuroda Y. Evaluation of gastroenteric bypass for unresectable pancreatic cancer. Hepatogastroenterology 2001; 48: 563-8.
25. Watanapa P, Williamson RCN. Surgical palliation for pancreatic cancer. Developments during the past two decades. Br J Surg 1992; 79: 8-20.
26. Lillemoe KD, Cameron JL, Hardacre JM, Shon TA, Sauter PK, Coleman J, Pitt HA, Yeo CJ. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 1999;230: 322-8.
27. Sohn TA, Lillemoe KD, Cameron JL, Huang JJ, Pitt HA, Yeo CJ. Surgical palliation of unresectable periampullary adenocarcinoma in the 1990s. J Am Coll Surg 1999; 188: 658-66.
28. Feretis C, Benakis P, Dimopoulos C, Manouras A,Tsimbloulis B, Apostolidis N. Duodenal obstruction caused by pancreatic head carcinoma: palliation with self-expandable endoprostheses. Gasrointest Endosc 1997; 46: 161-5.
29. Kouloulias VE, Nikita KS, Kouvaris JR, Golematis BC, Uzunoglu BK, Mystakidou K, Vlahos LJ. Intraoperative hyperthermia and chemoradiotherapy for inoperable pancreatic carcinoma. Eur J Cancer Care 2002;11: 100-7.
30. Smith AC, Dowsett JF, Russell RCG, Hatfield ARW, Cotton PB. Randomized trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 1994; 344: 1655-60